News
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback